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Stem cells have been used in the clinic for very speciﬁc
pathologies, but research has been conducted to develop
new therapies for a wider range of human diseases. Cur-
rently, there is a great need for step-by-step investigations
that consider all aspects related to cell therapy in disease-
speciﬁc contexts. The objective of this special issue is to bring
together timely reviews as well as original papers on diﬀerent
aspects related to the use of stem cells or their progeny
in transplantation procedures that can positively modify
degenerating or accidentally damaged tissues and organs.
A considerable number of manuscripts were submitted,
and after peer review, eight papers were published. The
topics of these papers are diverse, including the generation
of immortalized cells with inducible systems, the biological
behavior of transit-amplifying cells, the expansion capacity
of mesenchymal cells over hematopoietic cells, and the inﬂu-
ence of growth factors in the maintenance of a diﬀerentiated
phenotype. Regarding transplantation procedures, the non-
immunogenic intrauterine grafting of muscle cells and cell
replacement therapies for retinal degenerative conditions
are reviewed. Evaluation scales to assess the eﬀects of thera-
pies including cells and biocompatible support agents after
damage to the spinal cord are also discussed. Grafting of plu-
ripotent stem cell products poses a risk for the development
of teratomas; thus, several factors were studied to identify
strategies to eliminate tumorigenic cells. We think that
these papers cover several of the areas that are important
for the proper handling of stem cells to become therapeuti-
cally relevant and suggest improvements on the evaluation
after grafting of biological materials, which in the long term
might lead to new therapeutic interventions.
The paper by K. An et al. presents a potentially relevant
tool for the analysis of stem-cell based therapies in the ﬁeld
of pain therapy. First, they immortalized rat bone marrow
mesenchymal stromal cells (BMSCs) by introducing the
human telomerase reverse transcriptase (hTERT). Then, they
introduced a tetracycline-inducible lentivirus delivery system
to express the rat GAL gene into the immortalized rat
BMSCs. The authors further characterized the phenotypic
properties of these cells and conﬁrmed their ability to pro-
duce GAL in a doxycycline-controlled manner. Finally, the
authors advise that further studies are necessary to rule-out
the possibility of transformation after long-term expansion
of hTERT-BMSCs and to eliminate the leakiness of this
inducible system.
The ﬁeld of in utero transplantation (IUT) has, until
recently, been focused on the hematopoietic system. The
review by N. Chowdhury and A. Asakura comprehensively
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describes the literature on in utero stem cell transplantation,
covering hematopoietic applications as well as multiple
other cell types and organ systems. The detection of genetic
disorders in utero is now possible due to advances in cell-
free fetal DNA diagnostics in maternal blood. This provides
an opportunity for intervention and the application of in
utero stem cell transplantation therapies. The authors
explore the emerging area of IUTs for muscle disorders, in
particular muscular dystrophies. Attempts to treat children
with muscular dystrophy with muscle stem cell transplanta-
tions have failed partially due to the sheer number of cells
needed to treat a patient. One solution outlined in detail by
the authors is to treat the fetus in utero by transplantation
of muscle stem cells.
Human adipose-derived stem cells (hASCs) are a source
of diﬀerentiated cells that could be employed in regenerative
medicine. A. E. Mortimer et al. examine the role of diﬀerent
stimuli in the in vitromaintenance of Schwann-like cells pro-
duced from hASCs. Authors found that basic ﬁbroblast
growth factor (FGF-2) was essential for the maintenance of
the Schwann-like phenotype. In contrast, diﬀerentiation
was partially preserved in absence of glial growth factor 2
(GGF-2), platelet-derived growth factor (PDGF), or forsko-
lin. The lack of forskolin in the culture medium reduced
mRNA and protein levels of brain-derived neurotrophic
factor (BDNF), suggesting that an elevated cAMP concen-
tration and the consequent CREB activation are required
for BDNF expression. Finally, they identiﬁed that GGF-2
alone supports the expression of Krox20, a transcription
factor indispensable for myelination. The evidence pre-
sented in this paper indicates that maintenance of the
Schwann-like cells requires the synergistic activation of
diﬀerent signaling pathways.
The paper by O. Gordeeva and S. Khaydukov explores
the diﬀerences in the diﬀerentiation potential between
embryonic stem (ES) cells and embryonal carcinoma (EC)
cells in a retinoic acid diﬀerentiation protocol. During diﬀer-
entiation, the ES cells lost pluripotency markers, such asOct4
andNanog, more readily than EC cells and then gained some,
but not all, diﬀerentiation markers with faster kinetics. In
particular, Activin A, BMP4, TGFβ1, and Nodal were more
highly expressed in diﬀerentiating ES cells when compared
to EC cells. The addition of these TGFβ superfamily mem-
bers as recombinant proteins to the diﬀerentiation condi-
tions further enhanced loss of pluripotent markers and
increase commitment to diﬀerentiated lineages. This also
further reduced the tumorigenicity in teratoma assays. This
work shows that activation of TGFβ signaling in ES cells
can decrease their tumorigenicity and increase their safety
proﬁle for cell-based therapies.
The review by E. Rangel-Huerta and E. Maldonado
describes the diﬀerent biological properties of transit ampli-
fying cells (TACs), early intermediates in tissue regeneration.
With special focus on epidermal skin studies, they discuss
important aspects of TACs such as gene expression proﬁles,
division rates, asymmetric cell division, and environmental
cues that may regulate their behavior. The authors propose
that understanding TACs’ biology is a key issue for their
implementation in regenerative medicine.
Transplantation of stem cell-derived retinal pigmented
epithelium (RPE) has already began in human clinical trials.
However, there are no universally agreed upon animal
models to assess the eﬃcacy and safety of these therapies to
treat these retinal degenerative conditions. The review by
T.-C. Lin et al. systematically surveys all the animal models
in use for this type of stem cell-based therapy. They cover
mouse, rat, rabbit, dog, cat, pig, and nonhuman primate
models of preclinical retinal degeneration. Since the therapies
are using human cells, they discuss various methods to deal
with immunosuppression in the animal models. A particu-
larly novel one is the description of the crossing of immuno-
deﬁcient nude rats (Foxn1-null) to the RCS rat that suﬀers
from a progressive form of retinal degeneration. Although
the larger animal models are useful for reﬁning the surgical
techniques, the rodent studies have the beneﬁt of larger ani-
mal numbers and genetic manipulation to more closely
model the human condition. A consensus on the most infor-
mative models of eﬃcacy and safety for testing RPE cell
products requires further exploration.
Spinal cord injury (SCI) is a common lesion in accidents,
which cause disability in people; currently, there are no eﬃ-
cient therapeutic interventions in the clinic. The review paper
by W. R. Kim et al. relates to the importance of having grad-
ing scales that are both easy to use and reproducible to assess
the damage, as well as the recovery, on experimental animals
subjected to SCI. The damage to this part of the central ner-
vous system can have severe and long-lasting aﬀections to the
anatomy and the function of motor aspects that are greatly
inﬂuenced by the extension and the anteroposterior position
of the injury. After describing the most widely used animal
models for SCI, a summary of the beneﬁcial eﬀects of stem
cell grafting, either alone or combined with biomaterials, is
presented. This section clearly shows that several types of
cells, trophic factors, and polymers can all contribute to the
correction of disturbed functions. The ﬁnal part discusses
the diﬀerent scales to measure spinal cord function for
rodents and nonhuman primates, highlighting its advantages
and limitations.
Mesenchymal stromal cells are found in the bone marrow
and contribute to the microenvironment that preserves
hematopoietic stem cells in vivo. Mesenchymal stem/stromal
cells (MSCs) have also been isolated from other sources such
as adipose tissue, umbilical cord, and placenta. Hematopoi-
etic stem and progenitor cells (HPCs) can be expanded or
diﬀerentiated by coincubation with bone marrow MSCs
in vitro. Perinatal sources of MSCs such as the umbilical cord
and placenta are more accessible than the bone marrow
aspirates. In the paper by G. R. Fajardo-Orduña et al.,
the ability of cord blood and placenta MSCs to expand HSCs
was compared to the standard bone marrow MSCs. After
immunophenotypic and functional characterization of the
three types of MSCs, the expansion potential for primitive
HSCs was tested without signiﬁcant diﬀerences between the
diﬀerent MSCs. Also, the induction of myeloid colony form-
ing units was very similar for bone marrow, umbilical cord,
and placenta. These results suggest that MSCs from diﬀerent
origins might be used in the expansion of HSCs aimed
to transplantation.
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